NCT03282435Unknown1 期
Treatment of Non-small Cell Lung Cancer With CIK Cells Blocked by PD-1 Antibody
Dalian University0 个研究点目标入组 30 人开始时间: 2018年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 30
- 主要终点
- progression-free survival
研究概览
简要总结
to evaluate the prognosis of non-small cell lung carcinoma patients under CIK cellular treatment with PD-1 blocking on top of the standard therapy
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •non-small cell lung cancer;
- •more than 50% tumor tissues positive with PD-L1;
- •EGFR and ALK wild type
- •no other tumors
排除标准
- •with systematic diseases shortening survival
结局指标
主要结局
progression-free survival
时间窗: 5 years
metastasis-free survival
时间窗: 5 years
次要结局
未报告次要终点
研究者
相似试验
Unknown
不适用
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine KinaseNon-Small-Cell Lung CancerNCT02755337Dr. Soetomo General Hospital70
已完成
不适用
Non-small Cell Lung Cancer and Quality of LifeNon Small Cell Lung CancerNCT00818402University of Turku130
已完成
4 期
Chemotherapy Combined With CIK Treating Colon CancerColorectal CancerCytokine-induced Killer CellsPostoperative ComplicationsSurvivalNCT03084809China Meitan General Hospital46
已完成
不适用
tritional Assessment in Non-small Cell lung cancer patientslungcancerNon Small Cell Lung Cancer10038666NL-OMON50451Antoni van Leeuwenhoek Ziekenhuis100
招募中
1 期
Pentixafor Positron Emission Tomography Scan: A New Imaging Test for Staging in Non-small Cell Lung Canceron-small cell lung cancerCancer - Lung - Non small cellNon-small cell lung cancerACTRN12615001265561Oceanic Molecular Imaging30